CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company
Silence Therapeutics plc
Sign in to watch- Tickers
- SLN SLNCF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44-0-20-3457 6900
- Business address
- 12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP
Securities
- SLN American Depository Share Nasdaq
- SLNCF Common stock OTC
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-1 Offering Registration Statement for Certain Foreign Private Issuers
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
Page 14 of 14 · 277 filings